Crossmark

The evaluation of atorvastatin as an adjunct to fluconazole for the anti-fungal prophylaxis in acute myeloid leukemia: a multicenter, triple-blinded, randomized clinical trial

Crossref DOI link: https://doi.org/10.1007/s00210-023-02892-w

Published Online: 2023-12-14

Published Print: 2024-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Saber-Moghaddam, Niloufar

Nodeh, Mohammad Moeini

Ghavami, Vahid

Rahimi, Hossein

Azimi, Sajjad Ataei

Seddigh-Shamsi, Mohsen

Kamandi, Mostafa

Allahyari, Abolghasem

Shariatmaghani, Somayeh Sadat

Elyasi, Sepideh

Arasteh, Omid
License Information

Text and Data Mining valid from 2023-12-14

Version of Record valid from 2023-12-14
More Information

Article History

Received: 18 October 2023

Accepted: 4 December 2023

First Online: 14 December 2023

Declarations

:

: The local Ethics Committee of Mashhad University of Medical Sciences (MUMS) approved the study protocol (reference number: IR.MUMS.REC.1400.095), and registered on the Iranian registry of clinical trials as IRCT20210503051166N1. All participants were explained and informed for protocol of study and signed written consent forms.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below